
23 Feb Autolus
Brent Rice, Chief Commercial Officer
Oct. 11 | 4:15pm | Aseptic Technologies Ballroom
London, UK
(NASDAQ: AUTL)
In-person Presentation
Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing benefits to cancer patients.